SEE IF YOU CAN TELL FACT FROM FICTION. From cost savings to Candida, Clinical Mythbusters tackles questions you face every day. To get Clinical Mythbusters FREE every month, sign up now!

 

 

 

 

<previous>  <next>

 

 

Beyond increasing the cost of treatment, healthcare-associated infections (including central line associated bloodstream infections) can significantly reduce the average hospital’s profit margin.

 

True

 

In February 2007 the Association for Professionals in Infection Control & Epidemiology (APIC) published a briefing titled "Dispelling The Myths: The True Cost of Healthcare-Associated Infections." In it, the authors reported on a recent study of 1.69 million admissions at 77 hospitals; this revealed that patients with a healthcare- acquired infection reduced overall net inpatient profit margins by a total of $286 million (or $5,018 per infected patient). The study also found that "in classes where reimbursement is lower, the loss impact is even greater."(1)

 

To bolster their point about infections eroding profitability, the APIC briefing's authors cite the results of a 40-hospital campaign by the Jewish Health Foundation and Pittsburgh Regional Health Initiative to eliminate central line associated bloodstream infections (CLABs). The experience at Allegheny General Hospital was especially noteworthy. This institution reduced CLABs by 90%, and in doing so recorded the following data:

 

Average reimbursement per case
$64,894
Average cost per case with CLAB
$91,733
Average Loss per case
$(26,839)
Total Loss from operations associated with CLABs
$(1,449,306)
Percent of total cost of care associated with CLABs
43%

 

 

REFERENCES:

(1) Murphy, D., Whiting, J. “Dispelling The Myths: The True Cost of Healthcare-Associated Infections.” An APIC Briefing, Feb. 2007.

 

See the full list of mythbusters

Learn what's true and false about catheters and sign up for
our free bulletin on catheters and related subjects